From San Diego, California, USA:
I have been tested with an A1c of 7.3 and was told this is high. First of all, what is this a test of? What is the "normal" range for this? Should my low dose of glyburide be "taking care of" this problem, if indeed it is a problem?
A hemoglobin A1c test is a test that is not integrated into the care of patients with diabetes around the globe. It is the gold standard for determining the level of chronic glucose control. The assay specifically measures the amount of the hemoglobin protein in the blood that has been attached to glucose. The amount of glucose that attaches to the protein is dependant on the amount of glucose in the blood from one day to the next. The test is a good indicator of your average daily blood sugar over the previous three months. All the chronic long-term outcomes studies dealing with diabetes, both type 1 and type 2 diabetes, have been studied in relation to the hemoglobin A1c test. The normal range varies from laboratory to laboratory and depends on the methodology used by each laboratory. Most assays have a normal range up to 6.0%. The American Diabetes Association recommends that patients maintain their hemoglobin A1c levels at a level that is 1% of the normal range. However, it is preferable to have a normal level, provided that hypoglycemia does not limit this from occurring. In your particular situation, you have to go back to your physician and ask whether your medication needs to be adjusted to tighten your level of control.
Original posting 26 Jul 2006
Posted to A1c, Glycohemoglobin, HgbA1c
Last Updated: Tuesday April 06, 2010 15:10:08
This Internet site provides information of a general nature and is designed for educational purposes only. If you have any concerns about your own health or the health of your child, you should always consult with a physician or other health care professional.
This site is published by T-1 Today, Inc. (d/b/a Children with Diabetes), a 501c3 not-for-profit organization, which is responsible for its contents.
© Children with Diabetes, Inc. 1995-2016. Comments and Feedback.